Does celiac neuropathy favour Guillain-Barre syndrome following immunisation with the CoronaVac vaccine?

Resumen

Letter to the Editor, We read with interest the article by Wimmer del Solar et al. about a 50 years old female with a history of celiac disease, who developed flaccid quadriparesis two days after having received the first dose of the CoronaVac vaccine (Sinovac Life Science, China) [1]. Gullain-Barre syndrome (GBS) subtype acute, motor and sensory axonal neuropathy (AMSAN) was diagnosed and intravenous immunoglobulins were begun, leading to incomplete recovery [1]. It was concluded that the index patient is the first one who developed GBS following a CoronaVac vaccination [1]. The study is promising but raises concerns that should be discussed. Read more...